www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語(yǔ)Fran?ais
China
Home / China / Innovation

Chinese scientists give big boost to cancer-killing virus

Xinhua | Updated: 2017-08-24 14:41

Chinese scientists have found a compound that helped a tumor-targeting virus kill liver cancer more effectively while sparing healthy cells, offering new hope for treating the world's second most common cancer killer, according to a study published Wednesday.

A therapy using viruses that selectively kill cancer cells, dubbed oncolytic viruses, is rapidly progressing through clinical evaluation, but the therapeutic efficacy in humans has been less than expected from preclinical studies, according to the study published in the U.S. journal Science Translational Medicine.

Oncolytic virotherapy involving M1 virus, a mosquito-borne pathogen that predominantly causes mild illness in horses, is believed to be a potentially attractive strategy for the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

In order to boost the virus's antitumor effects, Professor Guangmei Yan of Sun Yat-sen University in China and colleagues screened 350 small molecules to identify compounds that can enhance viral killing of cultured HCC cells.

The researchers found that Eeyarestatin I, an inhibitor of the protein VCP, which has been linked to causing malignancy, as the strongest sensitizer for M1 virus, as it increased the potency of the virus by as much as 3,600-fold against the HCC cells.

The dual regimen had no effect on non-cancerous cells, they said.

In multiple mouse models of HCC, M1 together with Eeyarestatin I were found to shrink tumors and significantly prolong survival.

The researchers further demonstrated that the duo was safe and well-tolerated in monkeys.

"We can describe the M1 oncolytic virus as a guided missile that automatically targets tumor cells, and the addition of the VCP inhibitor is just like binding the missile to powerful explosives with the ability of auto-selection," Yan explained to Xinhua.

"The outcome is self-evident with such a strong combination," he said.

Yan said they plan to submit a clinical trial application for the combination therapy strategy in 2018.

"Hepatocellular carcinoma is the second leading cause of cancer-related death in men and claims more than 700,000 lives per year worldwide," their paper wrote. "Our study identifies combined VCP inhibition and oncolytic virus as a potential treatment for HCC and demonstrates promising therapeutic potential."

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲在线视频播放 | 国产91一区二这在线播放 | 国产精品福利午夜h视频 | 99久久免费中文字幕精品 | 美女视频免费黄 | 亚洲炮网 | 盗摄偷拍a在线观看 | 九九在线偷拍视频在线播放 | 亚洲精品国产综合99久久一区 | 亚洲欧美精品中文字幕 | 欧美一级毛片免费网站 | 韩国一级性生活片 | 中文字幕 日韩在线 | 国产一级做a爰片在线看 | 成人公开视频 | 91免费国产精品 | 青青青青爽视频在线播放 | 成人免费xxx色视频 成人免费大片a毛片 | 国产一区二区不卡 | 中文字幕一区二区三区精彩视频 | 欧美精品色精品一区二区三区 | 亚洲精品国产手机 | 99久国产 | 久久久久久网站 | 三级视频在线观看 | 免费看一级毛片欧美 | 久草com| 在线看片欧美 | 欧美一区三区 | 国产免费久久精品99 | 成人免费视频一区二区 | 国产高清自拍视频 | 久久久久久免费视频 | 爽死你个放荡粗暴小淫货双女视频 | 亚洲精品一区二区三区第四页 | 色综合色狠狠天天久久婷婷基地 | 国产成人丝袜网站在线看 | 精品自拍视频 | 日本免费高清视频二区 | 日韩中文字幕在线免费观看 | 成人综合网址 |